Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides for Joint Pain: Full Comparison

BPC-157 VEGF upregulation, angiogenesis stimulation, collagen synthesis activation via growth hormone receptor binding Tendons, ligaments, joint capsules, cartilage 200–500 mcg daily (animal studies); human dosing extrapolated from body weight Multiple peer-re

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • BPC-157
  • VEGF upregulation, angiogenesis stimulation, collagen synthesis activation via growth hormone receptor binding
  • Tendons, ligaments, joint capsules, cartilage
  • 200–500 mcg daily (animal studies); human dosing extrapolated from body weight
  • Multiple peer-reviewed animal studies; limited human trial data
  • Most studied for tendon healing and gastric tissue repair; mechanism supports joint application but direct human cartilage trials are sparse
  • TB-500
  • Actin binding, cell migration promotion, fibroblast differentiation, downregulation of inflammatory cytokines
  • Ligaments, tendons, muscle-tendon junctions
  • 2–5 mg twice weekly (research protocols)
  • Animal models published in peer-reviewed journals; human data primarily anecdotal
  • Strong mechanistic rationale for soft tissue injuries; evidence for scar tissue reduction is compelling but requires controlled human trials
  • Glucosamine Sulfate
  • Provides substrate for glycosaminoglycan synthesis; no receptor-mediated signaling
  • Articular cartilage (theoretical)
  • 1,500 mg daily (standard supplement dose)
  • Extensive human trials with mixed results; 2019 JAMA meta-analysis found no significant benefit vs placebo
  • Substrate without signal. Mechanism doesn't address repair activation; may help in early-stage OA but evidence is weak
  • Chondroitin Sulfate
  • Substrate for cartilage matrix; mild anti-inflammatory effect through cytokine modulation
  • Articular cartilage
  • 800–1,200 mg daily (standard supplement dose)
  • Large trials show minimal effect on joint space narrowing or pain scores
  • Similar limitation to glucosamine. Provides material but not the cellular instruction to use it effectively